Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of TXNRD1, HSPA4L and ATP1B1 Genes Associated with the Freezability of Boar Sperm. | Int J Mol Sci | 2022 | 36012584 | PubTator, text mining | PubMed |
| Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status. | Cancers (Basel) | 2022 | 36010941 | PubTator, text mining | PubMed |
| Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells. | Cells | 2022 | 36010649 | PubTator, text mining | PubMed |
| Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases. | Antioxidants (Basel) | 2022 | 36009283 | PubTator, text mining | PubMed |
| Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer. | Antioxidants (Basel) | 2022 | 36009263 | PubTator, text mining | PubMed |
| Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders. | Antioxidants (Basel) | 2022 | 36009187 | PubTator, text mining | PubMed |
| Selenocysteine Machinery Primarily Supports TXNRD1 and GPX4 Functions and Together They Are Functionally Linked with SCD and PRDX6. | Biomolecules | 2022 | 36008942 | PubTator, text mining | PubMed |
| DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy. | Exp Mol Med | 2022 | 35999456 | PubTator, text mining | PubMed |
| Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects. | Front Nutr | 2022 | 35990343 | PubTator, text mining | PubMed |
| Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis. | J Med Chem | 2022 | 35984756 | PubTator, text mining | PubMed |
| Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization. | PLoS One | 2022 | 35980883 | PubTator, text mining | PubMed |
| Hydrophobic cavity-directed azide-acetyllysine photochemistry for profiling non-histone interacting partners of bromodomain protein 1. | RSC Chem Biol | 2022 | 35975005 | PubTator, text mining | PubMed |
| Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC. | Circulation | 2022 | 35959657 | PubTator, text mining | PubMed |
| Bioinformatics analysis of lncRNAs in the occurrence and development of osteosarcoma. | Transl Pediatr | 2022 | 35958002 | PubTator, text mining | PubMed |
| Advances in the Study of the Mechanism by Which Selenium and Selenoproteins Boost Immunity to Prevent Food Allergies. | Nutrients | 2022 | 35956310 | PubTator, text mining | PubMed |
| Effect of Physical Activity/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging. | Int J Mol Sci | 2022 | 35955849 | PubTator, text mining | PubMed |
| Insulin prevents fatty acid induced increase of adipocyte size. | Adipocyte | 2022 | 35946137 | PubTator, text mining | PubMed |
| Biochemical and molecular assessment of selenium forms for the alleviation of oxidative stress in senescent human fibroblasts. | Gen Physiol Biophys | 2022 | 35938964 | PubTator, text mining | PubMed |
| Selective cellular probes for mammalian thioredoxin reductase TrxR1: rational design of RX1, a modular 1,2-thiaselenane redox probe. | Chem | 2022 | 35936029 | PubTator, text mining | PubMed |
| Cellular senescence: the good, the bad and the unknown. | Nat Rev Nephrol | 2022 | 35922662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=51